LDS/Medical Tests/Centromere Antibody, IgG

Centromere Antibody, IgG

Centromere antibodies are a type of anti-nuclear antibody (ANA) that occur in various autoimmune disorders, but are found mainly in patients with CREST syndrome. CREST syndrome is a form of scleroderma that can cause many symptoms including Raynaud’s syndrome, joint pain, limb numbness, tight skin, gastrointestinal disease, and many others. CREST syndrome is not curable and is a slowly progressive disorder. Because this disease does not usually involve deep organs, prognosis is good. Steroid and other medicine can lessen the severity of the symptoms. Although 25% percent of patients with Raynaud's syndrome have anti-centromere antibodies, they are also seen in patients with primary biliary cirrhosis, systemic lupus erythematosus, rheumatoid arthritis, and Sjögren's syndrome. In CREST syndrome, patients typically lack Scl-70 antibodies. The predictive value of a positive test is >95% in scleroderma.

Centromere antibodies were originally detected by their distinctive pattern of speckled nuclear staining in the antinuclear antibody (ANA) test. They were also found to react with several centromere proteins of 18 kDa, 80 kDa, and 140 kDa named CENP-A, CENP-B, and CENP-C. When the centromere pattern is present, other tests should be performed and the clinical symptoms should be reviewed before making a diagnosis of CREST or other scleroderma-type disorder.

  • In diagnosis of CREST syndrome
  • In evaluation of systemic sclerosis including skin involvement
  • In evaluation of Raynaud's phenomenon and arthralgias
  • As an aid in evaluation of other autoimmune disorders such as systemic lupus, Sjögren's syndrome, and occasionally rheumatoid arthritis

Positive in:

  • CREST syndrome
  • Scleroderma
  • Raynaud’s syndrome
  • Primary Biliary cirrhosis
  • Sjogren's syndrome
  • Systemic lupus erythematosus
  • Mixed connective tissue disease
  • Rare: Myositis, Rheumatoid arthritis, Autoimmune hepatitis, Primary pulmonary hypertension

Note:  The titer of anti-centromere antibody is considerably less in diseases other than CREST.

Result Value Interpretation
29 AU/mL or less Negative
30-40 AU/mL Equivocal
41 AU/mL or greater Positive

Method: Immunofluorescence Method Result: Negative

Enzyme Immunoassay (EIA), ELISA.

Serum (SST) or Plasma EDTA (Lavender), Heparin (Green). 

Stability

  • Ambient: 48 hours
  • Refrigerated: 7 days
  • Frozen: 60 days
Anti-Nuclear Antigen, Autoimmune Disease Specific Antigen Profile, Erythrocyte Sedimentation Rate, Rheumatoid Factor, Topoisomerase Antibody, Anti-Scl-70 Antibodies, Lupus Anticoagulant, Anti-mitochondrial antibody, Anti-LKM antibody.
1-2 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Am J Med. 1997 Sep;103(3):242-8.[ PMID: 9316557]
  • J Rheumatol. 2005 Aug;32(8):1488-94 [PMID: 16078324]
  • Arthritis Res Ther. 2003;5:80. [PMID: 12718748]
  • Rheumatology (Oxford). 2005;44:1212. [PMID: 15870151]
  • Centromere Antibodies, Serum. In Mayo Interpretive Handbook (pp. 169-170). Rochester: Mayo Medical Laboratories (2009).